Kintara Therapeutics, Inc.: Invitation to the Q2 Virtual Investor Summit

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. DELL
2. MDT
3. PANW
4. SPY
5. AAPL
6. SPGI
7. USO
8. ENOV
9. GTLB
10. AON

May 11, 2021 7:04 AM EDT

San Diego, California--(Newsfile Corp. - May 11, 2021) - Kintara Therapeutics, Inc. (NASDAQ: KTRA) today announced that Saiid Zarrabian, President & CEO will be attending the Q2 Virtual Investor Summit.

EventQ2 Investor Summit
DateMay 17-18th, 2021
PresentationMay 18th at11:00am ET
Locationhttps://zoom.us/webinar/register/WN_CaBoy6ovRySXUDmri34bUA

About Kintara Therapeutics, Inc.

Kintara (NASDAQ: KTRA) is dedicated to the development of novel cancer therapies for patients with rare unmet medical needs. Kintara is currently developing two Phase 3-ready therapeutics, VAL-083 for glioblastoma multiforme (GBM) and REM-001 for cutaneous metastatic breast cancer (CMBC).

For further information:

Kintara Therapeutics, Inc.
Jules Abraham
917-885-7378
[email protected]

About the Investor Summit

The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q2 Investor Summit will take place virtually, featuring 80+ companies and over 300 institutional and retail investors.

To request complimentary investor registration: please visit our website atwww.investorsummitgroup.com

Contact:

Sasha Murray at [email protected]


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Newsfile, Press Releases